Keloids: clinical features and management. Part I
DOI:
https://doi.org/10.66344/jpad.16.2.2006.856Keywords:
Keloid, hypertrophic scars, clinical features, managementAbstract
Keloids are benign tumours of fibrous origin which clinical ly present as firm, fesh-coloured tumours. The exact etiology is not known; nevertheless, there have been many associated dermatoses. Therapeutically, keloids have been a challenging disease and not a single effective therapy is available. The present review presents the clinical features and therapeutic update of this common malady.ÂReferences
Burton JL, Lovell CR. Disorders of connective tissue. In: Champion RH, Burton JL, Burns DA, Breathnach SM, eds. Textbook of Dermatology. Oxford: Blackwell Science; 1998. p. 2003-71.
From L, Assaad D. Neoplasms, pseudoneoplasms and hyperplasias of the dermis. In Freedberg IM, Eisen AZ, Wolff K et al., eds. Dermatology in General Medicine. New York: McGraw-Hill; 1999. p. 1161-75.
Child FJ, Fuller LC, Higging EM, Vivier DU. A study of the spectrum of skin disease occurring in a black population in South-East London. Br J Dermatol 1999; 141: 512-7.
Shaffer JJ, Taylor SC, Cook-Bolden F. Keloidal scars: a review with a critical look at theratpeutic options. J Am Acad Dermatol 2002; 46: 63-97.
Kuflik EG. Cryosurgery updated. J Am Acad Dermatol 1994; 31: 925-44.
Ragoowansi R, Paul GS, Glees JP. Treatment of keloids by surgical excision and immediate postoperative single-fraction radiotherapy. Plast Rec Sur 2003; 111: 1853-9.
Granstein RD, Rook A, Thomas J, Amento EP. A controlled trial of intralesional recombinant interferon-ï§ in the treatment of keloidal scarring. Arch Dermatol 1990; 126: 1295-1302.
Graham FG. Cryosurgery. In: Freedberg IM, Eisen AZ, Wolff K et al., eds. Dermatology in General Medicine. New York: McGraw-Hill; 1999. p. 2980-7.
Layton AM, Yip T, Cunliffe WJ. A comparison of intralesional triamcinolone and cryosurgery in the treatment of acne keloids. Br J Dermatol 1994; 130: 498-501.
Dawber R, Colves G, Jackson A, eds. Cutaneous Cryosurgery. London: Martin Dunitz; 1997.
Brody GS. Keloids and hypertrophic scars. Plast Reconstr Surg 1990; 86: 804.
Heenan PJ. Tumors of the fibrous tissue involving the skin. In Elder D, Elenitsas R, Jaworsky C, Johnson B, eds. Lever’s Histopathology of the Skin. New York: Lipincott-Raven; 1997. p. 847-87.
Cobbold CA. The role of nitric oxide in the formation of keloid and hypertrophic lesions. Med Hypotheses 2001; 57: 497-502.
Naitoh M, Hosokawa N, Kubota H et al. Upregulation of HSP47 and collagen type III in the dermal firbotic disease, keloid. Biochem Biophys Res Commun 2001; 280: 1316-22.
Luo S, Benathan M, Raffoul W et al. Abnormal balance between proliferation and apoptotic cell death in firboblasts derived from keloid lesions. Plast Recon Sur 2001; 107: 87-96.
Rodland KD, Muldoon LL, Magun BE. Cellular mechanisms of TGF-ï¢ action. J Invest Dermatol 1990; 94: 33S-40S.
Heckmann M, Grill BCA, Hein R, Kriegs T. Biphasic effects of interleukin-1ï¡ on dermal fibroblasts: enhancement of chemotactic responsiveness at low concentrations and of mRNA expression for collagenase at high concentrations. J Invest Dermatol 1993; 100: 780-4.
Hebda PA, Collins MA, Tharp MD. Mast cell and myofibroblast in wound healing. Dermatol Clin 1993; 11: 685-96.
Garner WL, Karmiol S, Rodriguez JL et al. Phenotypic difference in cytokine responsiveness of hypertrophic scar versus normal dermal fibroblasts. J Invest Dermatol 1993; 101: 875-9.
Lim IJ, Phan TT, Bay BH et al. Fibroblasts co-cultured with keloid keratinocytes: normal fibroblasts secrete collagen in a keloid like manner. Am J Physiol Cell Physiol 2002; 283: C212-22.
Meyer LJM, Stern R. Age dependent changes of hyaluronan in human skin. J Invest Dermatol 1994; 102: 385-9.
Murray JC. Scars and keloid. Dermatol Clin 1993; 11: 697-708.
Tuan TL, Huayang WU, Eunice Y et al. Increased plasminogen activator inhibitor-1 in keloid fibroblasts may account for their elevated collagen accumulation in fibrin gel cultures. Am J Pathol 2003; 162: 1579-89.
Peltonen J, Hsiao LL, Jaakkola S et al. Activation of collagen gene expression in keloids: co-localization of type-I and VI collagen and transforming growth factor ï¢1 mRNA. J Invest Dermatol 1991; 97: 240-8.
Richard AFC, Denver CO. Cutaneous tissue repair. Basic biologic consideration. Am Acad Dermatol 1985; 13: 710-25.
Pettinger DA, Yager DR, Diegelmann RF, Cohen IK. The effect of TGF-ï¢ on keloid fibroblast proliferation and collagen synthesis. Plast Reconr Surg 1996; 98: 827-33.
Glat PM, Longaker MT. Wound healing. In: Aston SJ, Beasley RW, Thome CHM. Grabb and Smith’s Plastic Surgery, 5th edn. Philadelphia: Lippincott-Raven; 1997. p. 3-12.
Lim IJ, Phan TT, Tan WTL, Longaker MT. Investigation of the influence of keloid-derived keratinocytes on fibroblast growth and proliferation in vitro. Plast Recon Surg 2001; 107: 797-808.
Datubo-Brown DD. Keloids: a review of the literature. Br J Plast Surg 1990; 43: 70-7.
Tsao SS, Dover JS, Arndt KA, Kaminer MS. Scar management: Keloid, hypertrophic, atrophic and acne scars. Semin Cutan Med Surg 2002; 21: 46-75.
Niessen FB, Spaumen PH, Schalkwij KJ et al. On the nature of hypertrophic scars and keloids: a review Plast Recon Surg 1999; 104: 1435-58.
Gold MH. A controlled clinical trial of topical silicone gel sheeting in the treatment of hypertrophic scars and keloids. J Am Acad Dermatol 1994; 30: 56-7.
Downloads
Published
How to Cite
Issue
Section
License
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.
